Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Lenalidomide × Dermatologic × Clear all

Phase

Status

Completed 11 Terminated 4 Active not recruiting 2 Withdrawn 1 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 34 Plasma cell 20 Other hematologic neoplasm 7 Myeloid 3 Gastrointestinal 2 Tumor-Agnostic 1 Thoracic 1 Sarcoma 1 Other solid neoplasm 1 Head & Neck 1 Dermatologic 1 CNS 1

Conditions

Lymphoma, T-Cell, Cutaneous 1

Interventions

Nivolumab 24 pembrolizumab 18 Ipilimumab 15 Temozolomide 13 toripalimab 9 Cyclophosphamide 9 Biopsy 9 Blood Specimen Collection 8 Dacarbazine 7 camrelizumab 6 Imiquimod 6 trametinib 5 fludarabine 5 dabrafenib 5 atezolizumab 5 aldesleukin 5 Cisplatin 5 Chemotherapy, Adjuvant 5 fludarabine phosphate 4 durvalumab 4 binimetinib 4 apatinib 4 Sorafenib 4 Interleukin-2 4 Injections 4 Gene Expression Profiling 4 Bevacizumab 4 Aminolevulinic Acid 4 palbociclib 3 methyl 5-aminolevulinate 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01132989 2010-05-28

REvMM2009

Florida Academic Dermatology Centers

Phase 2 Unknown

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon ⚡